university website

Verhoeff, S.R. (S. R.), Es, S. (S.), Boon, E. (E.), van Helden, E. (E.), L. Angus (Lindsay), S.G. Elias (Sjoerd), S.F. Oosting (Sjoukje), E.H.J.G. Aarntzen (Erik), A.H. Brouwers (A.), S. Heskamp (Sandra), et al. O.S. Hoekstra (Otto), H.M.W. Verheul (Henk), Van der Veldt, A.A.M. (A. A.M.), E.G.E. de Vries (Elisabeth), O.C. Boerman (Otto), W.T.A. van der Graaf (Winette), W.J. Oyen (Wim) and C.M.L. Herpen (Carla)

2018-10-01

Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

Publication

Publication

Annals of Oncology , Volume 29 p. viii314- viii315

Additional Metadata
Persistent URL doi.org/10.1093/annonc/mdy283.097, hdl.handle.net/1765/125531
Journal Annals of Oncology
Organisation Erasmus MC: University Medical Center Rotterdam
Citation
Verhoeff, S.R. (S. R.), Es, S. (S.), Boon, E. (E.), van Helden, E. (E.), Angus, L., Elias, S., … Herpen, C. (2018). Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC). Annals of Oncology, 29, viii314–viii315. doi:10.1093/annonc/mdy283.097
Free Full Text ( Final Version , 110kb ) cover


User Publication Person Organisation Collection
Close